Brief: Atara Biotherapeutics- Appointed Eric Hyllengren To Serve As Chief Operating Officer, In Addition To Role As CFO
15/10/2024 21:10
Oct 15 (Reuters) - Atara Biotherapeutics Inc ATRA.O :
* ATARA BIOTHERAPEUTICS- APPOINTED ERIC HYLLENGREN TO SERVE
AS
CHIEF OPERATING OFFICER, IN ADDITION TO ROLE AS CFO
Source text for Eikon: ID:n0001193125-24-237582
Further company coverage: ATRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing